
Daljeet Kohli of IndiaNivesh is obviously buoyed by the success of his earlier two stock picks, Alembic Pharma & J. B. Chem. Both stocks have given hefty returns and are still looking good for more gains. His latest stock pick, Cadila Healthcare, has been an under-performer so far. However, a re-rating is on the cards for Cadila and there will be a 20% gain, says Daljeet confidently
Recent Comments